CTOs on the Move

Spero Health

www.sperohealth.com

 
When it comes to treating addiction to opioids and other substances, there`s no single magic bullet. Rather, it takes a combination of tools to surround patients with care and keep them on the road to recovery. Spero Health delivers outpatient care to treat patients close to home in their own environments so they can cope with life as they overcome addiction. We create an individualized treatment plan for each patient using a pioneering, proven, three-pronged approach: 1. Evidence-based physician services • Physician visit • Mental and physical health screenings • Individualized recovery plan • Medication-assisted treatment, which may include Suboxone® ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Edward Littlejohn
Chief Operating Officer Profile

Similar Companies

Interbiolab

Interbiolab is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Regional MRI

Regional MRI is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advacare Home Services

Advacare Home Services is a Bridgeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genicon

Genicon is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Onkos Surgical Inc

Patrick Treacy, Antony Koblish and Adele Oliva saw a unique opportunity for one company to demonstrate leadership and set the agenda for innovation in surgical oncology. Founded in 2015, with best-in-class innovation partners, Onkos Surgical will deliver high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients. From modular segmental systems to customized solutions and patient specific products, Onkos Surgical will partner with surgeons to provide new innovations to help address complex cases. Onkos Surgical has capabilities to increase the speed and delivery of innovation. Onkos Surgical is leveraging new technologies, such as 3D printing, to meet the unique needs of the cancer patient or surgeon. Onkos Surgical will develop products for both hard and soft-tissue applications while continuing to explore strategic partnerships to differentiate our product portfolio. With great customer responsiveness, manufacturing lead-times and quality, our vision is to be able to service and support the needs of the surgical oncologist.